NSE:SANOFI NYSE:SA SANOFI TRADING STRATEGY - NEXT WEEK Stock losing momentum after hitting BOLU and entering rangebound in a descending triangle pattern on 1D charts. MACD line moving below signal line, Aroon Down has cut Aroon Up from below, and RSI moving towards its bearish support of 50-60. STRATEGY Short when price moves below the triangular support...
Breakout in Sanofi , round bottom and finally have breakout
Long Term breakout Strong fundamentals and healthy balance sheet Big player in domestic pharma brands Buy for long term targets of 12k + in year
Chart is self explanatory. Entry, Targets and Stop Loss are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
This is follow-up on Sanofi India. Can check link to related ideas. Target 1 achieved. More than 6%. Target 2 is ON. Chart is self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please...
Sanofi breakout... Watch it go beyond 9000 Let me know your views please...
Levels mentioned on chart. SL based on daily closing.
buy sanofi above 8400 for target of 8900+
#SwingTrading #BullishFlag #Sanofi Bullish flag pattern in Weekly chart of Sanofi India Ltd
Sanofi is looking good on charts. Good breakout with volume. Can test ATM in few weeks
Sanofi weekly breakout with good volumes
Sanofi is breaking falling trendline. Keep on radar.
STOCK IS IN UPTREND..NOW IN CORRECTION STAGE..BULLISH FLAG IS FORMING..IF BREAKOUT COMES AND SUSTAINS THEN BULLISH FIAG WILL BE CONFIRMED..THEN STRONG UPMOVE WILL COME..ALL CHARECTERISTICS ARE VISIBLE..FOR A LEARNER .. GOOD STUFF TO OBSERVE
ONE CAN GO LONG AT CURRENT LEVELS . STRONG SUPPORT AT 7400-7600 LEVELS. IF MARKET CORRECTS ONE CAN AVG BUY AT 7500-7600 LEVELS. STOPLOSS BELOW 7400 CLOSING BASIS.
Looks good it has broken the box and phase 3 approval has got covid vaccine